Astellas Pharma 4503.T (JPX) at JPY 2,132.00 as market closed 30 Jan 2026: earnings outlook

4503.T stock closed at JPY 2,132.00 on JPX on 30 Jan 2026 as investors reposition ahead of Astellas Pharma’s upcoming earnings report. The price sits near the 50-day average of JPY 2,101.24 and well above the 200-day average of JPY 1,671.30. Volume reached 11,090,800.00 shares, a 1.06x relative volume, signalling notable trader interest before results. This earnings spotlight explains why the upcoming report matters, how fundamentals and technicals shape short-term risk, and what Meyka AI’s grade and forecast imply for investors.